- call +1-201-465-4211
- email sales@mrinsights.biz
HPV infections can infect the genital areas of men including the skin on and around the penis or anus. These infections can also be spread to the mouth and the throat. Even when HPV infections are persistent to the male population and can cause severe diseases such as genital warts, anal cancers, penile cancers, and cancers of the oropharynx, there is currently no HPV test recommend for men. The approved tests available in the market are for screening women for cervical cancers. They are not useful for the screening of HPV-related cancers or genital warts in men.
Scope of the Report:
The global Human Papillomavirus (HPV) Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Papillomavirus (HPV) Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Human Papillomavirus (HPV) Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Papillomavirus (HPV) Testing market by product type and applications/end industries.
Market Segment by Companies, this report covers
Roche
Agilent Technologies
Becton, Dickinson and Company
Qiagen N.V.
Thermo Fisher Scientific Inc.
Abbott Laboratories
Hologic Inc.
Cepheid Inc.
Seegene Inc.
Takara Bio Inc.
DaAn Gene of Sun Yat-Sen University
Promega Corporation
Greiner Bio-One International GmbH (Greiner Holding AG)
Enzo Biochem Inc.
Norgen Biotek
DiagCor Bioscience Inc Ltd
Hybribio Limited
Zytovision GmbH
Arbor Vita Corporation
Medical & Biological Laboratories Co., Ltd
Fujirebio Diagnostics
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pap Smear Test
HPV DNA Test
Market Segment by Applications, can be divided into
Diagnostic Centers
Hospitals
Clinic
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Human Papillomavirus (HPV) Testing Market Overview
1.1 Product Overview and Scope of Human Papillomavirus (HPV) Testing
1.2 Classification of Human Papillomavirus (HPV) Testing by Types
1.2.1 Global Human Papillomavirus (HPV) Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Types in 2017
1.2.3 Pap Smear Test
1.2.4 HPV DNA Test
1.3 Global Human Papillomavirus (HPV) Testing Market by Application
1.3.1 Global Human Papillomavirus (HPV) Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Clinic
1.4 Global Human Papillomavirus (HPV) Testing Market by Regions
1.4.1 Global Human Papillomavirus (HPV) Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Human Papillomavirus (HPV) Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Papillomavirus (HPV) Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Papillomavirus (HPV) Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Human Papillomavirus (HPV) Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Papillomavirus (HPV) Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Human Papillomavirus (HPV) Testing (2013-2023)
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Human Papillomavirus (HPV) Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Roche Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Agilent Technologies
2.2.1 Business Overview
2.2.2 Human Papillomavirus (HPV) Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Agilent Technologies Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 Becton, Dickinson and Company
2.3.1 Business Overview
2.3.2 Human Papillomavirus (HPV) Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Becton, Dickinson and Company Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Qiagen N.V.
2.4.1 Business Overview
2.4.2 Human Papillomavirus (HPV) Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Qiagen N.V. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 Thermo Fisher Scientific Inc.
2.5.1 Business Overview
2.5.2 Human Papillomavirus (HPV) Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Thermo Fisher Scientific Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 Abbott Laboratories
2.6.1 Business Overview
2.6.2 Human Papillomavirus (HPV) Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Abbott Laboratories Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hologic Inc.
2.7.1 Business Overview
2.7.2 Human Papillomavirus (HPV) Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Hologic Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cepheid Inc.
2.8.1 Business Overview
2.8.2 Human Papillomavirus (HPV) Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cepheid Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Seegene Inc.
2.9.1 Business Overview
2.9.2 Human Papillomavirus (HPV) Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Seegene Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Takara Bio Inc.
2.10.1 Business Overview
2.10.2 Human Papillomavirus (HPV) Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Takara Bio Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.11 DaAn Gene of Sun Yat-Sen University
2.11.1 Business Overview
2.11.2 Human Papillomavirus (HPV) Testing Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 DaAn Gene of Sun Yat-Sen University Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.12 Promega Corporation
2.12.1 Business Overview
2.12.2 Human Papillomavirus (HPV) Testing Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Promega Corporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.13 Greiner Bio-One International GmbH (Greiner Holding AG)
2.13.1 Business Overview
2.13.2 Human Papillomavirus (HPV) Testing Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Greiner Bio-One International GmbH (Greiner Holding AG) Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.14 Enzo Biochem Inc.
2.14.1 Business Overview
2.14.2 Human Papillomavirus (HPV) Testing Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Enzo Biochem Inc. Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.15 Norgen Biotek
2.15.1 Business Overview
2.15.2 Human Papillomavirus (HPV) Testing Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Norgen Biotek Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.16 DiagCor Bioscience Inc Ltd
2.16.1 Business Overview
2.16.2 Human Papillomavirus (HPV) Testing Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 DiagCor Bioscience Inc Ltd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.17 Hybribio Limited
2.17.1 Business Overview
2.17.2 Human Papillomavirus (HPV) Testing Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Hybribio Limited Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.18 Zytovision GmbH
2.18.1 Business Overview
2.18.2 Human Papillomavirus (HPV) Testing Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Zytovision GmbH Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.19 Arbor Vita Corporation
2.19.1 Business Overview
2.19.2 Human Papillomavirus (HPV) Testing Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Arbor Vita Corporation Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.20 Medical & Biological Laboratories Co., Ltd
2.20.1 Business Overview
2.20.2 Human Papillomavirus (HPV) Testing Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Medical & Biological Laboratories Co., Ltd Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
2.21 Fujirebio Diagnostics
2.21.1 Business Overview
2.2.2 Human Papillomavirus (HPV) Testing Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Fujirebio Diagnostics Human Papillomavirus (HPV) Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Papillomavirus (HPV) Testing Market Competition, by Players
3.1 Global Human Papillomavirus (HPV) Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Papillomavirus (HPV) Testing Players Market Share
3.2.2 Top 10 Human Papillomavirus (HPV) Testing Players Market Share
3.3 Market Competition Trend
4 Global Human Papillomavirus (HPV) Testing Market Size by Regions
4.1 Global Human Papillomavirus (HPV) Testing Revenue and Market Share by Regions
4.2 North America Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
4.5 South America Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
5 North America Human Papillomavirus (HPV) Testing Revenue by Countries
5.1 North America Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
5.2 USA Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
6 Europe Human Papillomavirus (HPV) Testing Revenue by Countries
6.1 Europe Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
6.2 Germany Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
6.3 UK Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
6.4 France Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Countries
7.1 Asia-Pacific Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
7.2 China Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
7.5 India Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
8 South America Human Papillomavirus (HPV) Testing Revenue by Countries
8.1 South America Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
8.2 Brazil Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Human Papillomavirus (HPV) Testing by Countries
9.1 Middle East and Africa Human Papillomavirus (HPV) Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Human Papillomavirus (HPV) Testing Revenue and Growth Rate (2013-2018)
10 Global Human Papillomavirus (HPV) Testing Market Segment by Type
10.1 Global Human Papillomavirus (HPV) Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Human Papillomavirus (HPV) Testing Market Forecast by Type (2018-2023)
10.3 Pap Smear Test Revenue Growth Rate (2013-2023)
10.4 HPV DNA Test Revenue Growth Rate (2013-2023)
11 Global Human Papillomavirus (HPV) Testing Market Segment by Application
11.1 Global Human Papillomavirus (HPV) Testing Revenue Market Share by Application (2013-2018)
11.2 Human Papillomavirus (HPV) Testing Market Forecast by Application (2018-2023)
11.3 Diagnostic Centers Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
11.5 Clinic Revenue Growth (2013-2018)
12 Global Human Papillomavirus (HPV) Testing Market Size Forecast (2018-2023)
12.1 Global Human Papillomavirus (HPV) Testing Market Size Forecast (2018-2023)
12.2 Global Human Papillomavirus (HPV) Testing Market Forecast by Regions (2018-2023)
12.3 North America Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
12.4 Europe Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
12.6 South America Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Human Papillomavirus (HPV) Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Human Papillomavirus (HPV) Testing Picture
Table Product Specifications of Human Papillomavirus (HPV) Testing
Table Global Human Papillomavirus (HPV) Testing and Rev
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
